1-3 of 3
Serena Kimi Perna, MD
Close
Sort by
Journal Articles

Rapidly-Generated EBV-Specific T Cells (EBVST-cells) to Treat Type 2 Latency Lymphoma

Rayne H. Rouce, MD, Birju Mehta, Sandhya Sharma, Serena Kimi Perna, MD, Benjamin Shin, Vicky Torrano, Fnu Spoorthi, Natalia Lapteva, PhD, Catherine M. Bollard, MD, Adrian P. Gee, PhD, Carlos A. Ramos, MD, Shannon Inman, Karen L. Hodgkin, Kurt C. Gunter, MD, Malcolm K. Brenner, MD PhD, Helen E. Heslop, MD, Cliona M. Rooney, PhD
Journal: Blood
Blood (2016) 128 (22): 2990.
https://doi.org/10.1182/blood.V128.22.2990.2990
Published: 2016
Journal Articles

IL15 Enhances Proliferation and Effector Function of Antigen-Specific Cytotoxic T Lymphocytes (CTLs) and Mitigates the Suppressive Action of Regulatory T Cells (Tregs).

Serena Kimi Perna, MD, Biagio De Angelis, PhD, Daria Pagliara, MD, Lan Zhan, Cliona M Rooney, PhD, Helen E. Heslop, MD, Malcolm K Brenner, MB, PhD, FRCP, FRCPath, Gianpietro Dotti, MD, Barbara Savoldo, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4088.
https://doi.org/10.1182/blood.V114.22.4088.4088
Published: 2009
Journal Articles

Rapid and Wide Immunereconstitution Obtained with HSV-TK Engineered Donor Lymphocyte Add-Backs Permits Long-Term Survival after haplo-HSCT.

Chiara Bonini, MD, Fabio Ciceri, MD, Maria Teresa Lupo Stanghellini, MD, Attilio Bondanza, MD, Zulma Magnani, PhD, Serena Kimi Perna, MD, Massimo Bernardi, MD, Jacopo Peccatori, MD, Paolo Servida, MD, Fulvio Crippa, MD, Shin Kaneko, MD, Veronica Valtolina, PhD, Monica Salomoni, PhD, Lucia Turchetto, PhD, Salvatore Toma, PhD, Catia Traversari, PhD, Paolo Bruzzi, MD, Luca Castagna, MD, Armando Santoro, MD, Jane Apperley, MD, Shimon Slavin, MD, Scialini Colombi, PhD, Corrado Gallo Stampino, MD, Marco Bregni, MD, Claudio Bordignon, MD
Journal: Blood
Blood (2006) 108 (11): 307.
https://doi.org/10.1182/blood.V108.11.307.307
Published: 2006